AVAC's Blog: P-Values

Daily oral PrEP is moving from an idea to an offering in more countries and communities every day. And in the places where it isn’t being offered, demand is growing! To help advocates track implementation on the ground in detail, AVAC has developed a new section of PrEP Watch (a clearinghouse of information on PrEP science, research, cost, access and advocacy) focused specifically on implementation efforts underway.

A nearly five-month long waiting game for a response from the World Health Organization regarding advocates’ concerns about its confusing and inaccurate statement on the relationship between some forms of hormonal contraception and HIV ended on April 5. Sadly, the response starts a new waiting game, since the long-awaited letter promised action on some, though not all, of the points raised in the original letter, with no timeline or process described for taking that action.

Brandon Harrison is a New York City based HIV advocate. He was not alone in his call for action after hearing CDC release its sobering projections at CROI, suggesting 1 in 2 black MSM in the US will become infected in their lifetime. This blog is one in a series written by community scholars who attended CROI 2016.

Long-time activist Gus Cairns wrote a piece highlighting the UK National Health Service’s silence around PrEP. Just hours later, NHS England released a statement announcing that a PrEP policy would not be included in the NHS’ June decision-making process as originally expected. HIV groups in the UK condemned the announcement.